{"disease":{"id":"major-bleeding","name":"major bleeding"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06147830","title":"A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":2202,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07039149","title":"Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Jordan Collaborating Cardiology Group","has_results":false},{"nct_id":"NCT06177704","title":"Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Institut universitaire de cardiologie et de pneumologie de Québec, University Laval","has_results":false},{"nct_id":"NCT04808934","title":"NOAC Portuguese Real World Study","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Pfizer","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}